At the International AIDS Conference in Rio de Janeiro, Lenacapavir is attracting global attention. The drug works like a vaccine, protecting against HIV for six months, offering new hope to slow the epidemic. But its high price could limit access in many parts of the world.

The show’s own verdict is on its page.